Tag Archives: C-Suite

New Year Night Stalkers: What Will Keep the C-Suiters Awake in 2011

New Year Night Stalkers Eight Strategic Issues that Should Keep “C Suiters” Reaching for the NoDoz in 2011 The consensus is that 2011 will be a bad year for big pharma.  It must confront a breaking wave of patent expirations, while fiscal retrenchment has created an innovation cycle in reverse as payers find new ways […]
Posted in compliance, Manufacturing, Marketing, R&D, Regulatory, Strategy, Technology | Also tagged , | 5 Comments

Government Crackdown on the C-Suite

Over the past decade, the drug industry has paid tens of billions of dollars to settle state and federal lawsuits involving the False Claims Act—defrauding Medicare and Medicaid, promoting drugs for unapproved uses, paying kickbacks to doctors and pharmacies, and the like. Stories about off-label promotion of drugs with serious adverse effects and no proven […]
Posted in Legal | Also tagged , , , , | Leave a comment
  • Categories

  • Meta